chr20-3889134-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_StrongBP6
The ENST00000702266.1(PANK2-AS1):n.40G>A variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000723 in 1,562,132 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00037 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000040 ( 1 hom. )
Consequence
PANK2-AS1
ENST00000702266.1 non_coding_transcript_exon
ENST00000702266.1 non_coding_transcript_exon
Scores
1
7
11
Clinical Significance
Conservation
PhyloP100: -0.301
Genes affected
PANK2 (HGNC:15894): (pantothenate kinase 2) This gene encodes a protein belonging to the pantothenate kinase family and is the only member of that family to be expressed in mitochondria. Pantothenate kinase is a key regulatory enzyme in the biosynthesis of coenzyme A (CoA) in bacteria and mammalian cells. It catalyzes the first committed step in the universal biosynthetic pathway leading to CoA and is itself subject to regulation through feedback inhibition by acyl CoA species. Mutations in this gene are associated with HARP syndrome and pantothenate kinase-associated neurodegeneration (PKAN), formerly Hallervorden-Spatz syndrome. Alternative splicing, involving the use of alternate first exons, results in multiple transcripts encoding different isoforms. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.03422314).
BP6
Variant 20-3889134-C-T is Benign according to our data. Variant chr20-3889134-C-T is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 935319.We mark this variant Likely_benign, oryginal submissions are: {Uncertain_significance=2, Likely_benign=1}.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PANK2-AS1 | XR_001754478.3 | n.40G>A | non_coding_transcript_exon_variant | 1/2 | ||||
PANK2 | NM_153638.4 | c.34C>T | p.His12Tyr | missense_variant | 1/7 | NP_705902.2 | ||
PANK2 | NM_001324192.1 | c.34C>T | p.His12Tyr | missense_variant | 1/2 | NP_001311121.1 | ||
PANK2 | NM_024960.6 | c.-246+230C>T | intron_variant | NP_079236.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PANK2 | ENST00000316562.9 | c.34C>T | p.His12Tyr | missense_variant | 1/7 | 1 | ENSP00000313377 | A2 | ||
PANK2-AS1 | ENST00000702266.1 | n.40G>A | non_coding_transcript_exon_variant | 1/1 | ||||||
PANK2 | ENST00000495692.5 | c.-538+118C>T | intron_variant | 3 | ENSP00000476745 | |||||
PANK2 | ENST00000497424.5 | c.-246+230C>T | intron_variant | 2 | ENSP00000417609 |
Frequencies
GnomAD3 genomes AF: 0.000374 AC: 57AN: 152214Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
57
AN:
152214
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000703 AC: 12AN: 170798Hom.: 0 AF XY: 0.0000328 AC XY: 3AN XY: 91350
GnomAD3 exomes
AF:
AC:
12
AN:
170798
Hom.:
AF XY:
AC XY:
3
AN XY:
91350
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000404 AC: 57AN: 1409800Hom.: 1 Cov.: 31 AF XY: 0.0000302 AC XY: 21AN XY: 696472
GnomAD4 exome
AF:
AC:
57
AN:
1409800
Hom.:
Cov.:
31
AF XY:
AC XY:
21
AN XY:
696472
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000368 AC: 56AN: 152332Hom.: 0 Cov.: 33 AF XY: 0.000376 AC XY: 28AN XY: 74494
GnomAD4 genome
AF:
AC:
56
AN:
152332
Hom.:
Cov.:
33
AF XY:
AC XY:
28
AN XY:
74494
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
4
ESP6500EA
AF:
AC:
0
ExAC
AF:
AC:
6
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Feb 08, 2024 | Variant summary: PANK2 c.34C>T (p.His12Tyr) results in a conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 7e-05 in 170798 control chromosomes (gnomAD). This frequency is not significantly higher than estimated for a pathogenic variant in PANK2 causing Pantothenate Kinase-Associated Neurodegeneration (7e-05 vs 0.0011), allowing no conclusion about variant significance. To our knowledge, no occurrence of c.34C>T in individuals affected with Pantothenate Kinase-Associated Neurodegeneration and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 935319). Based on the evidence outlined above, the variant was classified as uncertain significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 02, 2023 | The c.34C>T (p.H12Y) alteration is located in exon 1 (coding exon 1) of the PANK2 gene. This alteration results from a C to T substitution at nucleotide position 34, causing the histidine (H) at amino acid position 12 to be replaced by a tyrosine (Y). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Pigmentary pallidal degeneration Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Uncertain
D
MutationAssessor
Benign
N
MutationTaster
Benign
D;N
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Uncertain
Sift
Pathogenic
D
Sift4G
Uncertain
T
Polyphen
B
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at